ML21278B103

From kanterella
Revision as of 19:39, 19 November 2024 by StriderTol (talk | contribs) (StriderTol Bot change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Transcript - Fda and NRC Workshop on Enhancing Development of Targeted Alpha-Emitting Radiopharmaceuticals, Special Session on Actinium-225
ML21278B103
Person / Time
Issue date: 09/22/2021
From:
NRC/NMSS/DMSST/MSEB
To:
Sarah Lopas
References
NRC-1654
Download: ML21278B103 (249)
v • d • e


Text

Retrieved from "https://kanterella.com/w/index.php?title=ML21278B103&oldid=3745164"